Backed by rich industry experience, we are able to provide high quality Glatiramer Acetate CAS NO. 147245-92-9 to our customers. Glatiramer Acetate CAS 147245-92-9 is a random basic synthetic copolymer of L-alanine, L-lysine, l-glutamic acid and L-tyrosine in a molar ratio of 6:1.9:4.7:1. Glatiramer Acetate is suitble for treat relapsing-remitting multiple sclerosis, and it is administered by subcutaneous injection. According to experiment, side effects may include a lump at the injection site (injection site reaction) in approximately 30% of users, and aches, fever, chills (flu-like symptoms) in approximately 10% of users.

Thera. Category: Treatment of Multiple Sclerosis

Cas No.: 147245-92-9

Synonym: GLATIRAMER ACETATE;l-glutamic acid polymer with l-alanine, l-lysine and l-tyrosine, acetate (salt);511: PN: WO2010103292 PAGE: 64 claiMed sequence;L-Alanine polyMer with L-GlutaMic Acid L-Lysine L-Tyrosine Acetate;L-GlutaMic Acid peptide with L-Alanine L-Lysine L-Tyrosine Acetate Salt;L-Tyrosine polyMer with L-Alanine L-GlutaMic Acid L-Lysine Acetate;ProtiraMer;GaltiraMer acetate

Molecular Formula: C25H45N5O13

Molecular Weight: 623.65

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: It Glatiramer acetate is a random basic synthetic copolymer of L-alanine, L-lysine, l-glutamic acid and L-tyrosine in a molar ratio of 6:1.9:4.7:1. Glatiramer acetate is an immunomodulator used in treatment of multiple sclerosis